Alpha-Klotho is a high-purity recombinant protein widely investigated in cellular aging, renal physiology, and endocrine metabolic pathways. This definitive reconstitution guide provides precise dilution reference tables, mathematical formulas, and step-by-step laboratory handling protocols across all standard vial masses. Researchers can utilize these standardized parameters to achieve reproducible molar concentrations for in vitro and preclinical experimental setups.
Alpha-Klotho is a high-purity recombinant protein widely investigated in cellular aging, renal physiology, and endocrine metabolic pathways. This definitive reconstitution guide provides precise dilution reference tables, mathematical formulas, and step-by-step laboratory handling protocols across all standard vial masses. Researchers can utilize these standardized parameters to achieve reproducible molar concentrations for in vitro and preclinical experimental setups.
Alpha-Klotho (often referred to simply as Klotho) is a single-pass transmembrane protein that acts as an essential co-receptor for fibroblast growth factor 23 (FGF23), while its shed extracellular domain functions as a circulating humoral factor. In vitro assays and animal models demonstrate that Alpha-Klotho modulates broad physiological processes, including phosphate homeostasis, oxidative stress suppression, and Wnt signaling regulation. Because recombinant proteins require meticulous solvent integration to preserve tertiary structure, accurate dilution is vital when preparing stock solutions from lyophilized powders across all peptides and complex proteins.
When sourcing high-purity compounds such as Alpha-Klotho LR, investigators must account for exact peptide mass, buffer selection, and target working concentrations. Sub-optimal reconstitution procedures can lead to protein aggregation, partial denaturation, or imprecise assay dosing. This guide establishes standard volumetric protocols and offers access to our automated reconstitution calculator to support rigorous, repeatable laboratory workflows.
The table below details the resulting concentration (mg/mL) and microgram yield per 0.1 mL (100 µL) and 0.01 mL (10 µL) volumetric draw across common lyophilized vial sizes (1 mg, 2 mg, and 5 mg) when dissolved in standard diluent volumes. All parameters are intended strictly for laboratory analytical planning.
| Vial Mass (mg) | Diluent Volume (mL) | Final Concentration (mg/mL) | Yield per 0.1 mL (100 µL) | Yield per 0.01 mL (10 µL) | |---|---|---|---|---| | 1.0 mg | 0.5 mL | 2.0 mg/mL | 200 µg | 20 µg | | 1.0 mg | 1.0 mL | 1.0 mg/mL | 100 µg | 10 µg | | 1.0 mg | 2.0 mL | 0.5 mg/mL | 50 µg | 5 µg | | 2.0 mg | 0.5 mL | 4.0 mg/mL | 400 µg | 40 µg | | 2.0 mg | 1.0 mL | 2.0 mg/mL | 200 µg | 20 µg | | 2.0 mg | 2.0 mL | 1.0 mg/mL | 100 µg | 10 µg | | 2.0 mg | 4.0 mL | 0.5 mg/mL | 50 µg | 5 µg | | 5.0 mg | 1.0 mL | 5.0 mg/mL | 500 µg | 50 µg | | 5.0 mg | 2.5 mL | 2.0 mg/mL | 200 µg | 20 µg | | 5.0 mg | 5.0 mL | 1.0 mg/mL | 100 µg | 10 µg | | 5.0 mg | 10.0 mL | 0.5 mg/mL | 50 µg | 5 µg |
To verify batch-specific purity, molecular weight, and freeze-dried mass prior to volumetric calculations, researchers should consult the lot-specific certificate of analysis (COA) supplied with every PX1 Research order.
Calculating target concentration relies on the primary volumetric formula: C = M / V, where C represents final concentration (mg/mL), M represents total lyophilized mass (mg), and V represents total diluent volume (mL). Conversely, to determine the volume required for a target concentration, rearrange the formula to V = M / C.
Worked Example 1: A researcher possesses a 2.0 mg vial of Alpha-Klotho and requires a stock concentration of 1.0 mg/mL for microplate dosing. Applying the rearranged formula: V = 2.0 mg / 1.0 mg/mL = 2.0 mL. Adding 2.0 mL of sterile reconstitution vehicle yields a 1.0 mg/mL solution, where each 100 µL aliquot delivers exactly 100 µg of active research compound.
Worked Example 2: An assay protocol requires a working stock of 2.5 mg/mL using a 5.0 mg vial of Alpha-Klotho. Solving for volume: V = 5.0 mg / 2.5 mg/mL = 2.0 mL. Injecting 2.0 mL of vehicle yields 2.5 mg/mL, providing 250 µg per 100 µL injection or pipetted sample. For additional research regarding protein handling, explore our research library hub.
Recombinant Alpha-Klotho requires careful selection of solvent parameters to maintain structural integrity and prevent precipitation. Standard sterile bacteriostatic water (containing 0.9% benzyl alcohol) or phosphate-buffered saline (PBS, pH 7.2–7.4) are commonly utilized in short-term laboratory protocols. However, long-term storage of reconstituted proteins often necessitates the inclusion of a carrier protein, such as 0.1% Bovine Serum Albumin (BSA), to prevent nonspecific binding to plasticware surfaces.
In vitro data indicate that reconstituting recombinant proteins in highly acidic or excessively basic buffers can alter secondary protein folding, reducing binding affinity in FGF23 co-receptor binding assays. Researchers performing cell culture experiments should ensure the chosen solvent is non-cytotoxic and compatible with the media composition used in their assays.
Achieving consistent results across experimental replicates requires strict adherence to sterile laboratory techniques during peptide and protein reconstitution:
1. Decontaminate the rubber stopper of the Alpha-Klotho vial using an isopropyl alcohol wipe inside a certified laminar flow hood. 2. Equilibrate the lyophilized vial to room temperature (20°C to 25°C) for 20 minutes before adding liquid to prevent moisture condensation within the container. 3. Using a sterile polypropylene syringe or precision micropipette, draw the exact volume of diluent indicated by your concentration calculations. 4. Direct the liquid stream against the glass vial wall rather than spraying directly onto the lyophilized pellet to avoid mechanical shear stress. 5. Allow the solvent to submerge the pellet, then gently swirl the vial in a circular motion. Never vortex recombinant Alpha-Klotho, as vigorous agitation introduces air bubbles and promotes protein denaturation. 6. Inspect the solution visually. The final liquid should be completely clear and free of undissolved particulate matter before proceed to aliquoting.
In preclinical biogerontology studies, Alpha-Klotho is frequently evaluated alongside other regulatory signaling compounds targeting cellular senescence, mitochondrial performance, and genomic stability. For instance, FOXO4-DRI is a synthetic peptide studied for its selective induction of apoptosis in senescent cells by disrupting FOXO4-p53 interaction. Similarly, Epitalon is an endogenous pineal peptide researched for its role in telomerase activity activation, while SS-31 targets cardiolipin within the inner mitochondrial membrane to mitigate reactive oxygen species (ROS) production.
Unlike small synthetic peptides like Epitalon or SS-31, Alpha-Klotho is a large, complex protein with distinct solubilization kinetics. While small peptides dissolve rapidly in water, large recombinant proteins require careful handling and specific buffer conditions to prevent aggregation. Comparing these distinct classes allows investigators to map multi-pathway research models combining receptor-mediated signaling with cellular maintenance mechanisms.
Precision in quantitative assays depends entirely on the chemical purity and structural integrity of the starting material. PX1 Research subjects every batch of Alpha-Klotho to rigorous analytical validation in an ISO 17025 accredited laboratory facility. Purity is measured via High-Performance Liquid Chromatography (HPLC), guaranteeing structural uniformity above baseline standards.
Mass Spectrometry (MS) confirms exact molecular weight, verifying sequence fidelity and eliminating the risk of sequence truncations or residual processing artifacts. Additionally, bacterial endotoxin testing via Chromogenic LAL assay ensures endotoxin levels remain below 0.01 EU/µg. This clean profile eliminates inflammatory confounding factors during sensitive cell-line experiments or preclinical rodent models.
Lyophilized Alpha-Klotho should be stored at -20°C to -80°C in a manual defrost freezer away from light. Under these cold storage conditions, the dry powder maintains optimal stability for up to 24 months from the date of manufacture. Avoid freezers with automatic defrost cycles, as temperature fluctuations cause freeze-thaw degradation of the lyophilized matrix.
Once reconstituted, stock solutions in sterile PBS (containing 0.1% carrier protein like BSA) should be divided into single-use aliquoting tubes to avoid repeated freeze-thaw cycles. Reconstituted aliquots stored at -80°C maintain structural stability for up to 3–6 months. Working solutions kept at 2°C to 8°C should be utilized within 3 to 7 days to prevent structural degradation or microbial growth.
PX1 Research provides institutional laboratories and academic institutions with high-purity research compounds backed by complete batch transparency. All products are manufactured in GMP-compliant, USA-based facilities, guaranteeing stringency across every production run. Orders ship same-day (Monday through Friday) directly from our distribution hubs in California and Arizona.
For large-scale animal studies or high-throughput screening projects, investigators can establish institutional accounts through our wholesale portal to lock in bulk pricing and dedicated lot-reservation services. Learn more about our manufacturing standards and full catalog on our main research peptides resource hub.
What is the recommended diluent for reconstituting Alpha-Klotho?
For short-term in vitro assays, sterile phosphate-buffered saline (PBS, pH 7.2–7.4) or sterile bacteriostatic water is recommended. For long-term frozen storage, adding 0.1% Bovine Serum Albumin (BSA) as a carrier protein helps prevent nonspecific adsorption to plastic tubes.
Can I vortex Alpha-Klotho to accelerate dissolution?
No. Vortexing recombinant proteins generates severe shear stress and air-water interfaces that cause protein denaturation and aggregation. Reconstitution should always be performed by gentle swirling or slow inversion.
How do I calculate the volume needed for a specific concentration?
Use the formula Volume (mL) = Mass (mg) / Target Concentration (mg/mL). For example, a 1.0 mg vial requires 2.0 mL of diluent to produce a final working stock of 0.5 mg/mL.
What is the endotoxin limit for PX1 Research Alpha-Klotho?
PX1 Research tests every batch using chromogenic LAL assays to ensure endotoxin levels remain below 0.01 EU/µg, minimizing potential immune activation during cell culture assays or animal studies.
How long is reconstituted Alpha-Klotho stable at 4°C?
Reconstituted liquid stock solutions stored at 2°C to 8°C should be used within 3 to 7 days. For extended storage, divide into single-use aliquots and freeze at -80°C.
Where can I find the lot-specific purity data for my Alpha-Klotho vial?
Every product shipped by PX1 Research includes a batch lot number that corresponds to an online Certificate of Analysis (COA) containing HPLC chromatograms, mass spectrometry reports, and endotoxin assay results.
Why is a carrier protein like BSA recommended for low-concentration protein solutions?
At concentrations below 0.1 mg/mL, recombinant proteins adhere to polypropylene tubes and glass surfaces via hydrophobic interactions. Adding 0.1% BSA blocks non-specific binding sites on container walls, preserving calculated protein concentration.
Does PX1 Research offer institutional account discounts for bulk orders?
Yes. Research facilities and universities purchasing higher volume quantities can register through our wholesale program to access volume pricing and lot-reservation options.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.